HealthLynked Management

Management criteria checks 2/4

HealthLynked's CEO is Michael Dent, appointed in Jan 2017, has a tenure of 8.08 years. total yearly compensation is $36.84K, comprised of 91.3% salary and 8.7% bonuses, including company stock and options. directly owns 30.15% of the company’s shares, worth $5.74M. The average tenure of the management team and the board of directors is 1.1 years and 4.3 years respectively.

Key information

Michael Dent

Chief executive officer

US$36.8k

Total compensation

CEO salary percentage91.3%
CEO tenure8.1yrs
CEO ownership30.2%
Management average tenure1.1yrs
Board average tenure4.3yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Michael Dent's remuneration changed compared to HealthLynked's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$6m

Jun 30 2024n/an/a

-US$4m

Mar 31 2024n/an/a

-US$4m

Dec 31 2023US$37kUS$34k

-US$4m

Sep 30 2023n/an/a

-US$6m

Jun 30 2023n/an/a

-US$8m

Mar 31 2023n/an/a

-US$8m

Dec 31 2022US$36kUS$35k

-US$8m

Sep 30 2022n/an/a

-US$6m

Jun 30 2022n/an/a

-US$5m

Mar 31 2022n/an/a

-US$4m

Dec 31 2021US$37kUS$35k

-US$11m

Sep 30 2021n/an/a

-US$11m

Jun 30 2021n/an/a

-US$13m

Mar 31 2021n/an/a

-US$14m

Dec 31 2020US$35kUS$35k

-US$6m

Sep 30 2020n/an/a

-US$6m

Jun 30 2020n/an/a

-US$6m

Mar 31 2020n/an/a

-US$5m

Dec 31 2019US$50kUS$50k

-US$6m

Sep 30 2019n/an/a

-US$4m

Jun 30 2019n/an/a

-US$5m

Mar 31 2019n/an/a

-US$6m

Dec 31 2018US$66kUS$66k

-US$6m

Compensation vs Market: Michael's total compensation ($USD36.84K) is below average for companies of similar size in the US market ($USD640.24K).

Compensation vs Earnings: Michael's compensation has increased whilst the company is unprofitable.


CEO

Michael Dent (59 yo)

8.1yrs

Tenure

US$36,844

Compensation

Dr. Michael Thomas Dent, M.D. serves as the Chief Executive Officer of HealthLynked Corp. since January 2017 and serves as its Chairman. Dr. Dent is the Co-Founder and Managing Partner of Inlight Capital P...


Leadership Team

NamePositionTenureCompensationOwnership
Michael Dent
Founder8.1yrsUS$36.84k30.15%
$ 5.7m
Jeremy Daniel
Chief Financial Officerless than a yearno datano data
Bill Crupi
Chief Operating Officerless than a yearno data0.014%
$ 2.7k
Michael Paisan
Director of Investor Relations & Strategic Partnerships2.1yrsno datano data
Mark Cesal
Marketing Manager1.1yrsno datano data

1.1yrs

Average Tenure

Experienced Management: HLYK's management team is not considered experienced ( 1.1 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Michael Dent
Founderno dataUS$36.84k30.15%
$ 5.7m
Maher Albitar
Member of Scientific Advisory Board6.3yrsno datano data
Robert Gasparini
Independent Director5.8yrsUS$20.00k0.88%
$ 166.9k
George O'Leary
Directorno dataUS$269.16k0.35%
$ 66.8k
Heather Monahan
Independent Director4.3yrsUS$20.00k0.27%
$ 52.2k
Shawn Miller
Member of Medical Advisory Board5.4yrsno datano data
Pamela Hughes
Member of Medical Advisory Boardno datano datano data
Daniel Hall
Director4.3yrsUS$20.00k0.27%
$ 52.2k
Sam Diasti
Member of Medical Advisory Board3.5yrsno datano data
Paul Hobaica
Independent Director1.9yrsUS$35.00k0.069%
$ 13.1k
Paul Norman
Member of Advisory Board2.6yrsno datano data

4.3yrs

Average Tenure

59yo

Average Age

Experienced Board: HLYK's board of directors are considered experienced (4.3 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/02 03:21
End of Day Share Price 2025/01/31 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

HealthLynked Corp. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution